메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류
인문학
인문학 일반 역사학 철학 종교학 어문학 기타 인문학
사회과학
사회과학 일반 경영학 관광학 교육학 군사학 문헌정보학 법학 사회학 신문방송학 심리과학 정치외교학 지리학 행정학 경제학 무역학 인류학 기타 사회과학
자연과학
자연과학 일반 물리학 생물학 생활과학 수학·통계학 천문학 지구과학 화학 기타 자연과학
공학
공학 일반 건축공학 기계공학 산업공학 재료·에너지공학 전기전자공학 조선해양공학 화학공학 컴퓨터학 기타공학
의약학
의학 일반 간호학 수의학 약학 한의학 기초의학 임상의학 기타 의약학
농수해양학
농수해양학 일반 농학 수산학 식품과학 임학 축산학 해상운송학 기타 농수해양학
예술체육학
예술 일반 디자인 미술 미용 사진 음악학 의상 체육 공연매체예술 기타 예술체육학
복합학
학제간연구 과학기술학 뇌인지과학 기술정책 기타 복합학

ENG

추천
검색
질문

논문 기본 정보

자료유형
학술저널
저자정보
저널정보
대한생물치료정신의학회 생물치료정신의학 생물치료정신의학 제13권 제1호
발행연도
2007.6
수록면
62 - 74 (13page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색
질문

초록· 키워드

오류제보하기
Objectives : Memantine is a low to moderate affinity, uncompetitive N-methyl-D-aspartate(NMDA) receptor antagonist, which has been used to treat patients with moderate to severe dementia of the Alzheimer’s type. A few animal studies suggest a mechanism related to oxidative stress may be involved in the effect of memantine. The aims of this study are to evaluate whether administration of memantine causes change in a peripheral blood marker of oxidative stress, which may provide a clinical evidence of oxidative stress hypothesis, to identify influencing factors, and to suggest a peripheral blood marker of oxidative stress can be used to measure the effect of memantine in clinical practice.
Methods : The subjects were consisted with 66 patients(19 males and 47 females) admitted to the Gongju geriatric hospital from early January in 2006 thru the end of August in 2006 under the diagnosis of probable dementia of the Alzheimer’s type according to the DSM-IV and the NINCDS-ADRDA criteria. The control group was consisted with 60 healthy elderly(18 males and 42 females) who were compatible with sex, age and educational level of patient group. The demographic data were obtained by structured interviews. The cognitive disorder was assessed by the MMSE-K, severity of dementia by the CDR and the GDS, and function by the ADL. The serum total antioxidant capacity(TAC) was measured by chemiluminescence method, once in the control group and three times(before memantine administration, 1 month after memantine administration and 2 months after memantine administration) in the patient group.
Results : 1) As compared with TAC before memantine administration(1.762±0.133m㏖/L), TAC(2.096±0.172 m㏖/L) increased significantly at 2 months after memantine administration(p＜0.001), which was significantly (p＜0.001, respectively) higher than TAC at 1 month after memantine administration(1.865±0.283m㏖/L) and TAC of normal aged controls(1.935±0.194m㏖/L). 2) The TAC of controls was significantly different according to age, educational levels and MMSE-K scores(p＜0.001, respectively). The TAC of patient group was significantly different according to MMSE-K scores(p＜0.005), CDR(p＜0.05), GDS(p＜0.05) and ADL(p＜0.005) before memantine administration, according to sex(p＜0.05) and age(p＜0.05) at 1 month after memantine administration, and according to ADL(p＜0.05) at 2 months after memantine administration. 3) The effect of mematine administration on the TAC correlated significantly with sex, age and duration of dementia(p＜0.05, respectively) at 1 month after memantine administration, so did with severity of de entia(CDR and GDS, p＜0.05 respectively) and function(ADL, p＜0.05) at 2 months after memantine administration.
Conclusion : To evaluate effect of memantine treatment on patients with moderate to severe dementia of the Alzheimer’s type, a peripheral blood marker of oxidative stress seemed to be preferable to clinical scales.
#NMDA receptor antagonist #Memantine #Moderate to severe dementia of the Alzheimer's type #Oxidative stress #Total antioxidant capacity #NMDA 수용체 길항제 #중등 도 내지 고도 알츠하이머형 치매 #산화스 트레스

목차

서론
대상 및 방법
결과
고찰
결론
참고문헌

참고문헌 (61)

참고문헌 신청
1. [학술지(정기간행물)] - Jann MW / 2005 / Cholinesterase inhibitors and similary acting compounds : 2808 ~ 2816 google schola 2. [학술지(정기간행물)] - Danysz W / 2003 / The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer's disease: preclinical evidence 18 : S23 ~ S32 google schola 3. [학술지(정기간행물)] - Flitt HM / 2002 / Achieving and maintaining cognitive vitality with aging 77 : 681 ~ 696 google schola 4. [학술지(정기간행물)] - Selkoe DJ / 2004 / Alzheimer disease: mechanistic understanding predicts novel therapies 140 : 627 ~ 638 google schola 5. [학술지(정기간행물)] - Grossberg GT / 2003 / Management of Alzheimer's disease 58A (4) : 331 ~ 353 google schola

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

이 논문과 함께 이용한 논문

알츠하이머형치매 환자에서 혈중 총항산화력 저하에 영향미치는 인자
전진숙 ,  김인성 ,  변현우 생물치료정신의학 2008 .12
경도인지장애와 알츠하이머형 치매 환자에서 혈중 Superoxide Dismutase 활성도와 Nitric oxide 및 Homocysteine 농도
김지은 ,  정성수 ,  이정구 외 8명 생물치료정신의학 2007 .12
Effects of Red Liriope platyphylla on NGF secretion ability, NGF receptor signaling pathway and γ-secretase components in NSE/hAPPsw transgenic mice expressing Alzheimer’s Disease
Sun-Il Choi ,  Jun-Seo Goo ,  Ji-Eun Kim 외 7명 Laboratory Animal Research 2012 .09
Peroxiredoxin Ⅰ regulates the component expression of γ-secretase complex causing the Alzheimer’s disease
Young Ju Lee ,  Jun Seo Goo ,  Ji Eun Kim 외 11명 한국실험동물학회 학술발표대회 논문집 2012 .02
Peroxiredoxin I regulates the component expression of γ-secretase complex causing the Alzheimer’s disease
Young Ju Lee ,  Jun Seo Goo ,  Ji Eun Kim 외 11명 Laboratory Animal Research 2011 .12

최근 본 자료

전체보기

댓글(0)

0

UCI(KEPA) : I410-ECN-0101-2009-513-015970646